tiprankstipranks
Advertisement
Advertisement

AU:NSB Stock Latest News

NeuroScientific advances StemSmart cell therapy with strong early Crohn’s data and scale-up plans
Company AnnouncementsNeuroScientific advances StemSmart cell therapy with strong early Crohn’s data and scale-up plans
18d ago
NSB
NeuroScientific scales up StemSmart manufacturing with Q-Gen for Phase 2 trials
PremiumCompany Announcements
NeuroScientific scales up StemSmart manufacturing with Q-Gen for Phase 2 trials
2M ago
NSB
NeuroScientific Revenue Surges but Half-Year Loss Deepens and Asset Base Shrinks
PremiumCompany Announcements
NeuroScientific Revenue Surges but Half-Year Loss Deepens and Asset Base Shrinks
3M ago
NSB
NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
PremiumCompany Announcements
NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
4M ago
NSB
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
PremiumCompany Announcements
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
4M ago
NSB
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
6M ago
NSB
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
Premium
Company Announcements
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
6M ago
NSB
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
Premium
Company Announcements
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
6M ago
NSB
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
6M ago
NSB
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
7M ago
NSB
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
7M ago
NSB
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
PremiumCompany Announcements
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
7M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
8M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
8M ago
NSB
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
8M ago
NSB
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
8M ago
NSB
Neuroscientific Biopharmaceuticals Issues New Equity Securities
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Issues New Equity Securities
8M ago
NSB
Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
9M ago
NSB
NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
9M ago
NSB
NeuroScientific Biopharmaceuticals Reports Promising Results for StemSmart MSC in Renal Transplantation
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Reports Promising Results for StemSmart MSC in Renal Transplantation
9M ago
NSB
NeuroScientific Biopharmaceuticals Highlights Stem Cell Innovations at TechKnow Invest Roadshow
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Highlights Stem Cell Innovations at TechKnow Invest Roadshow
9M ago
NSB
NeuroScientific Biopharmaceuticals Partners with Q-Gen to Advance StemSmart™ Technology
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Partners with Q-Gen to Advance StemSmart™ Technology
10M ago
NSB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >